Study of ZG005 in Combination With Gecacitinib and Chemotherapy for Participants With Advanced Solid Tumors
Clinical trial NCT07142837 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07142837
- Sponsor
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-01
- Primary completion
- 2027-10-01
- Enrollment
- 153
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.